1. 20 Transformation of EML4/ALK positive adenocarcinoma of the lung to small cell lung cancer following ALK targeted therapy. (January 2016) Authors: Lees, C.E.; Woodcock, V.; Nicholson, A.; Talbot, D. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A comparison of intraperitoneal versus extraperitoneal placement of pancreas transplant grafts. (April 2016) Authors: Figueiredo, R.; Moir, J.; Talbot, D.; Sen, G.; Manas, D.; Jaques, B.; White, S.; Wilson, C. Journal: HPB Issue: Volume 18(2016)Supplement 2 Page Start: e789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development and Validation of an Automotive Axle Power Loss Model. Issue 4 (3rd July 2016) Authors: Talbot, D.; Kahraman, A.; Li, S.; Singh, A.; Xu, H. Journal: Tribology transactions Issue: Volume 59:Issue 4(2016) Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase 1b/2 trial of taladegib (LY2940680), a Hh/Smo inhibitor, in combination with carboplatin and etoposide followed by taladegib maintenance in extensive-stage small-cell lung cancer. (December 2016) Authors: Schaefer, E.; Braiteh, F.; Forster, M.; Talbot, D.; Chandler, J.; Richards, D.; Andre, V.; Estrem, S.; Pitou, C.; Tiu, R.; Brail, L.; Nikolinakos, P. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗